News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Yüksel Ürün: Moderately hypofractionated radiotherapy is as effective as conventionally fractionated radiotherapy
Yüksel Ürün/X
Mar 27, 2025, 07:15

Yüksel Ürün: Moderately hypofractionated radiotherapy is as effective as conventionally fractionated radiotherapy

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Amar U Kishan, et al. on X:

“HYDRA Study (MARCAP):

Moderately hypofractionated radiotherapy (MHFRT) is as effective as conventionally fractionated radiotherapy (CFRT).
Dose-escalated MHFRT increases bowel toxicity without survival benefit.”

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium

Author: Amar U Kishan,et al.

Yüksel Ürün: Moderately hypofractionated radiotherapy is as effective as conventionally fractionated radiotherapy

More posts featuring Yüksel Ürün.

 

Amar U. Kishan cancer Cancer research MHFRT moderately hypofractionated radiotherapy OncoDaily Oncology prostate cancer Yüksel Ürün
Special Coverage
Insight
Aug 5, 2025, 05:07
Soheil Meshinchi: Our Second AML-Directed CAR T-Cell Therapy is Advancing to Clinical Implementation
Blog
Aug 5, 2025, 04:56
A Recent Report from the Nonpartisan Congressional Budget Office - AACR
Blog
Aug 5, 2025, 04:32
Carmen Uscatu: Every Beginning Must Have an End
Insight
Aug 4, 2025, 22:56
Richard Sullivan: Advanced Cell Therapies - Challenges for Global Health Systems
Blog
Aug 4, 2025, 22:44
Let’s Connect Across Disciplines to Shape the Future of Pediatric Oncology Together - SIOP
Blog
Aug 4, 2025, 21:47
Uma Borate: Helping The James' Patients Through Funding Cancer Research
Blog
Aug 4, 2025, 21:17
Rengaswamy Sankaranarayanan's Vision will Continue to Inspire Current and Future Public Health Professionals - IARC
Blog
Aug 4, 2025, 20:57
What Happens to the Donations and Sponsorships Received? - Dăruiește Viață
Career
Aug 4, 2025, 20:46
Honoring Julie Gralow’s Lifetime Achievement Award from India’s National Cancer Grid
Blog
Aug 4, 2025, 20:45
Why Cancer Prevention Must be Treated as a Global Systems Risk - IARC
Science
Aug 4, 2025, 20:39
Scott Kopetz: Hunting for the Very Rare Clonal Fusions for Clinical Benefit
Blog
Aug 4, 2025, 20:38
Radhakrishna Pillai: Remembering Dr. R. Sankaranarayanan - A Titan of Cancer Prevention